Fractyl aims to bring curative therapies to the large populations of patients with metabolic disease. With their innovative products, their goal is to truly shift the treatment paradigm for patients with metabolic disease by focusing on their root cause in the intestine to provide meaningful, transformative, benefits to restore patient health from metabolic diseases.

Biotechnology

Fractyl

Harith Rajagopalan

Adrian K.

Karen Hakenson

Timothy Kieffer

Helmut Giersiefen

Kelly White

Sarah Toomey

Jon Fitzgerald

Lisa Davidson

Jay Caplan

Len Rosberg

Clinical Research Team

Engineering Team

Leadership Team

Commercial and Marketing Team

Manufacturing and Operations Team

Quality Assurance Team

Finance and Administration Team

Teams at Fractyl